Related references
Note: Only part of the references are listed.BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression
Alessandro Tancredi et al.
CELL DEATH & DISEASE (2022)
The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response
Niamh Coleman et al.
BRITISH JOURNAL OF CANCER (2021)
SLFN11 informs on standard of care and novel treatments in a wide range of cancer models
Claudia Winkler et al.
BRITISH JOURNAL OF CANCER (2021)
Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines
Suleyman Vural et al.
CLINICAL EPIGENETICS (2021)
Navigating the DNA methylation landscape of cancer
Atsuya Nishiyama et al.
TRENDS IN GENETICS (2021)
Computational Prediction of Drug Responses in Cancer Cell Lines From Cancer Omics and Detection of Drug Effectiveness Related Methylation Sites
Rui Yuan et al.
FRONTIERS IN GENETICS (2020)
Drug mechanism-of-action discovery through the integration of pharmacological andCRISPRscreens
Emanuel Goncalves et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases
Sang-Min Jang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
MGMT Status as a Clinical Biomarker in Glioblastoma
Madison Butler et al.
TRENDS IN CANCER (2020)
Promoter DNA Hypermethylation and Paradoxical Gene Activation
Jim Smith et al.
TRENDS IN CANCER (2020)
Estimation of clinical trial success rates and related parameters
Chi Heem Wong et al.
BIOSTATISTICS (2019)
An evaluation of supervised methods for identifying differentially methylated regions in Illumina methylation arrays
Saurav Mallik et al.
BRIEFINGS IN BIOINFORMATICS (2019)
Cell Model Passportsa hub for clinical, genetic and functional datasets of preclinical cancer models
Dieudonne van der Meer et al.
NUCLEIC ACIDS RESEARCH (2019)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening
Gabriele Picco et al.
NATURE COMMUNICATIONS (2019)
Cancer Cell Lines Are Useful Model Systems for Medical Research
Peppino Mirabelli et al.
CANCERS (2019)
ELMER v.2: an R/Bioconductor package to reconstruct gene regulatory networks from DNA methylation and transcriptome profiles
Tiago C. Silva et al.
BIOINFORMATICS (2019)
Prognostic and Predictive Epigenetic Biomarkers in Oncology
Katarzyna Kaminska et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Correlation Patterns Between DNA Methylation and Gene Expression in The Cancer Genome Atlas
John C. G. Spainhour et al.
CANCER INFORMATICS (2019)
The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens
Dimitra Repana et al.
GENOME BIOLOGY (2019)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Exploration of drug-response mechanism by integrating genetics and epigenetics across cancers
Wenhua Lv et al.
EPIGENOMICS (2018)
Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance
Jone Michelena et al.
NATURE COMMUNICATIONS (2018)
Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response
Elizabeth A. Mazzio et al.
CANCER GENOMICS & PROTEOMICS (2018)
Characteristics of The Cancer Genome Atlas cases relative to US general population cancer cases
Xiaoyan Wang et al.
BRITISH JOURNAL OF CANCER (2018)
The germline genetic component of drug sensitivity in cancer cell lines
Michael P. Menden et al.
NATURE COMMUNICATIONS (2018)
Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
Sadegh Saghafinia et al.
CELL REPORTS (2018)
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
Yi-Long Wu et al.
LANCET ONCOLOGY (2017)
A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome
A. D. Kelly et al.
LEUKEMIA (2017)
The role of epigenomics in personalized medicine
Mohamad M. Kronfol et al.
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio et al.
CELL (2016)
Facilitating a culture of responsible and effective sharing of cancer genome data
Lillian L. Siu et al.
NATURE MEDICINE (2016)
OmniPath: guidelines and gateway for literature-curated signaling pathway resources
Denes Turei et al.
NATURE METHODS (2016)
Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review
Min Jia et al.
CLINICAL EPIGENETICS (2016)
Computational and Experimental Advances in Drug Repositioning for Accelerated Therapeutic Stratification
Khader Shameer et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents
C. Paiva et al.
CELL DEATH & DISEASE (2015)
Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
Brinton Seashore-Ludlow et al.
CANCER DISCOVERY (2015)
The NAE inhibitor pevonedistat (MLN4924) synergizes with TNF-alpha to activate apoptosis
F. S. Wolenski et al.
CELL DEATH DISCOVERY (2015)
As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect
Shuang Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
ChAMP: 450k Chip Analysis Methylation Pipeline
Tiffany J. Morris et al.
BIOINFORMATICS (2014)
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
Martin J. Aryee et al.
BIOINFORMATICS (2014)
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang et al.
CANCER CELL (2014)
FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E Mutation
Geoffrey Kim et al.
CLINICAL CANCER RESEARCH (2014)
A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response
Scott C. Smith et al.
NUCLEIC ACIDS RESEARCH (2014)
An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
Amrita Basu et al.
CELL (2013)
Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray
Yi-an Chen et al.
EPIGENETICS (2013)
Temporal regulation of EGF signalling networks by the scaffold protein Shc1
Yong Zheng et al.
NATURE (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values
Brent S. Pedersen et al.
BIOINFORMATICS (2012)
αA- and αB-Crystallins Interact with Caspase-3 and Bax to Guard Mouse Lens Development
W. -F. Hu et al.
CURRENT MOLECULAR MEDICINE (2012)
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Roel H. Wilting et al.
DRUG RESISTANCE UPDATES (2012)
Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan-Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer
Suresh S. Ramalingam et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
Gabriele Zoppoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
On the presence and role of human gene-body DNA methylation
Daudi Jjingo et al.
ONCOTARGET (2012)
methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles
Altuna Akalin et al.
GENOME BIOLOGY (2012)
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
Felix Krueger et al.
BIOINFORMATICS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Breast Cancer 2 Gene expression profiling in breast cancer: classification, prognostication, and prediction
Jorge S. Reis-Filho et al.
LANCET (2011)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
The Hox genes and their roles in oncogenesis
Nilay Shah et al.
NATURE REVIEWS CANCER (2010)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
Share Paper
